The role of brain histamine in acute and chronic stresses

被引:47
作者
Ito, C [1 ]
机构
[1] Tohoku Grad Univ, Sch Med, Dept Psychiat, Aoba Ku, Sendai, Miyagi 9808574, Japan
关键词
acute stress; brain histamine; chronic stress;
D O I
10.1016/S0753-3322(00)80069-4
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
As a neurotransmitter or neuromodulator, brain histamine has a variety of physiological roles in brain functions. Acute stress increases the histamine turnovers in the diencephalon, nucleus accumbens and striatum. Histamine regulates anterior pituitary hormones. Anxiolytic drugs also decrease brain histamine turnover. Histamine H1 receptor antagonists and H3 receptor agonists decrease the anxiety state. These findings show that acute stresses increase brain histamine turnover, especially in the diencephalon, which would be partly related to the pathology of anxiety. Moreover, chronic restraint stress continued to increase the histamine turnovers in the nucleus accumbens and striatum, not in the diencephalon. Chronic administration of psychostimulants also increase the striatal histamine release. Histamine agonists prevent psychostimulant-induced behavior and the development of behavioral sensitization. These results indicate that chronic stress continues to increase the histamine turnovers in the nucleus accumbens and striatum, which would have a role of preventing stress vulnerability. Moreover, histamine H3 receptor antagonists have antidepressive effects. Therefore, no increase of histamine turnover in the diencephalon is related to the pathology of depressive state. (C) 2000 Editions scientifiques et medicales Elsevier SAS.
引用
收藏
页码:263 / 267
页数:5
相关论文
共 54 条
[1]   BLOCKADE OF MUSCARINIC, HISTAMINE-H1 AND HISTAMINE-H2 RECEPTORS BY ANTIDEPRESSANTS [J].
ALVAREZ, FJ ;
VELASCO, A ;
PALOMARES, JL .
PHARMACOLOGY, 1988, 37 (04) :225-231
[2]  
BARNETT A, 1969, INT J NEUROPHARMACOL, V8, P73
[3]   INTERACTION OF ANTIDEPRESSANTS AND NEUROLEPTICS WITH HISTAMINE STIMULATED PARIETAL-CELL ADENYLATE-CYCLASE AND H+ SECRETION [J].
BEIL, W ;
HANNEMANN, H ;
SEWING, KF .
PHARMACOLOGY, 1988, 36 (03) :198-203
[4]  
CACABELOS R, 1985, BIOGENIC AMINES, V3, P9
[5]   THIOPERAMIDE, THE SELECTIVE HISTAMINE-H-3 RECEPTOR ANTAGONIST, ATTENUATES STIMULANT-INDUCED LOCOMOTOR-ACTIVITY IN THE MOUSE [J].
CLAPHAM, J ;
KILPATRICK, GJ .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1994, 259 (02) :107-114
[6]   HIGH-AFFINITY HISTAMINE H3-RECEPTORS REGULATE ACTH RELEASE BY ATT-20 CELLS [J].
CLARK, MA ;
KORTE, A ;
MYERS, J ;
EGAN, RW .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1992, 210 (01) :31-35
[7]   Role of the limbic system in dependence on drugs [J].
de Fonseca, FR ;
Navarro, M .
ANNALS OF MEDICINE, 1998, 30 (04) :397-405
[8]   HISTAMINE TURNOVER IN RAT-BRAIN [J].
DISMUKES, K ;
SNYDER, SH .
BRAIN RESEARCH, 1974, 78 (03) :467-481
[9]   ACUTE EFFECTS OF HISTAMINE ON PLASMA PROLACTIN AND LUTEINIZING-HORMONE LEVELS IN MALE RATS [J].
DONOSO, AO ;
BANNZA, AM .
JOURNAL OF NEURAL TRANSMISSION, 1976, 39 (1-2) :95-101
[10]  
DOUGLAS WW, 1985, PHARMACOL BASIS THER, P604